Finance

Lists
Why is SBS up 4.95%?
Dive Deeper
SBS:FRA
Stratec SE
€28.60
+4.95%
(+1.35) 1D
Nov 19, 8:04:02 AM GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for SBS...
Open
€28.60
High
€28.60
Low
€28.60
Mkt. cap
342.15M
Avg. vol.
82.00
Volume
0.00
Dividend
2.10%
Quarterly dividend
€0.15
Ex-dividend date
Jun 24, 2026
52-wk high
€28.60
52-wk low
€16.38
EPS
-€3.49
Shares outstanding
11.96M
No. of employees
1K
Open
€28.60
High
€28.60
Low
€28.60
Mkt. cap
342.15M
Avg. vol.
82.00
Volume
0.00
Dividend
2.10%
Quarterly dividend
€0.15
Ex-dividend date
Jun 24, 2026
52-wk high
€28.60
52-wk low
€16.38
EPS
-€3.49
Shares outstanding
11.96M
No. of employees
1K
News stories
From web sources and news partners
Profile
STRATEC SE is a company with worldwide operations that designs and manufactures fully automated analyzer systems for partners in clinical diagnostics and biotechnology - particularly in the field of in-vitro-diagnostics. As a classic original equipment manufacturer supplier, STRATEC produces its systems almost exclusively on behalf of its customers. Alongside the systems themselves, the company also provides sample preparation solutions, system software and integrated laboratory software. STRATEC is also responsible for development documentation, testing, delivery of systems, and the supply of spare parts and complex consumables for diagnostic and medical applications. STRATEC's customers are well known diagnostic companies like DiaSorin, Abbott, SIEMENS, Bio-Rad or Hologic. Wikipedia
About Stratec SE
CEO-
Employees1.35K
Founded1979
Headquarters-
SectorHealth Care
IndustryMedical device
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
75.28M
53.43M
59.11M
52.37M
Cost of goods sold
56.31M
43.22M
43.87M
33.93M
Cost of revenue
56.31M
43.22M
43.87M
33.93M
Research and development expenses
2.78M
1.72M
1.49M
2.96M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.82M
8.82M
9.64M
10.03M
Operating expense
11.19M
10.30M
9.66M
57.34M
Total operating expenses
67.50M
53.53M
53.54M
91.27M
Operating income
7.78M
-104.00K
5.57M
-38.90M
Other non operating income
219.00K
-65.00K
61.00K
125.00K
EBT including unusual items
-826.00K
-1.16M
5.43M
-39.89M
EBT excluding unusual items
5.55M
-1.16M
5.43M
-39.89M
Income tax expense
3.52M
557.00K
1.27M
615.00K
Effective tax rate
-426.03%
-48.18%
23.35%
-1.54%
Other operating expenses
-2.41M
-235.00K
-1.46M
44.36M
Net income
-4.34M
-1.71M
4.16M
-40.51M
Net profit margin
-5.77%
-3.21%
7.04%
-77.35%
Earnings per share
-
-
-
-
Interest and investment income
8.00K
34.00K
55.00K
-
Interest expense
-955.00K
-1.02M
-260.00K
-1.12M
Net interest expenses
-947.00K
-987.00K
-205.00K
-1.12M
Depreciation and amortization charges
-
-
-
-
EBITDA
10.71M
4.45M
10.03M
-13.07M
Gain or loss from assets sale
3.00K
-94.00K
-9.00K
72.00K
Upcoming events
AI content may include mistakes. Learn more
Google apps